REPLIGEN CORP

RGEN 10-K · FY 2025
API behind this page

RGEN FY 2025 request

Playground key active
Request URL /api/financials?ticker=RGEN&year=2025&quarter=4&full_year_mode=true
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric FY 2025 FY 2024 YoY
Cost of Revenue 352,011 359,794 -2.2%
Show Consolidation Items breakouts
Operating Segments 352,011 359,794 -2.2%
Total Costs & Expenses 683,089 669,553 +2.0%
Show Consolidation Items breakouts
Operating Segments 683,089 669,553 +2.0%
Research & Development 54,177 43,200 +25.4%
Show Consolidation Items breakouts
Operating Segments 54,177 43,200 +25.4%
Sales & Marketing (FY) — — —
Show Consolidation Items breakouts
Operating Segments 105,320 92,009 +14.5%
General & Administrative (FY) — — —
Show Consolidation Items breakouts
Operating Segments 171,581 174,550 -1.7%
Selling, General & Administrative 290,508 263,368 +10.3%
Operating Income 55,167 -35,114 +257.1%
Non-Operating Income (Expense) 7,216 8,079 -10.7%
Show Consolidation Items breakouts
Operating Segments 7,216 8,079 -10.7%
Interest Expense -21,513 -20,731 -3.8%
Other Non-Operating Income (Expense) 2,815 -5,174 +154.4%
Income Before Taxes 62,383 -27,035 +330.7%
Income Tax Expense (Benefit) 13,489 -1,521 +986.9%
Show Consolidation Items breakouts
Operating Segments 13,489 -1,521 +986.9%
Comprehensive Income 98,896 -40,239 +345.8%
EPS (Basic) 0.87 -0.46 +289.1%
EPS (Diluted) 0.86 -0.46 +287.0%
Wtd Avg Shares (Basic) 56,234 55,937 +0.5%
Wtd Avg Shares (Diluted) 56,561 55,937 +1.1%
Revenue From Contract With Customer Including Assessed Tax 738,256 634,439 +16.4%
Show Product Lines breakouts
Chromatography Products [Member] 153,176 122,810 +24.7%
Filtration Products [Member] 402,792 372,963 +8.0%
Other products [Member] 3,320 4,679 -29.0%
Process Analytics Products [Member] 81,237 59,301 +37.0%
Product 737,960 634,178 +16.4%
Proteins Products [Member] 97,435 74,425 +30.9%
Royalty 296 261 +13.4%
Show Consolidation Items breakouts
Operating Segments 738,256 634,439 +16.4%

Balance Sheet

Balance Sheet
Metric FY 2025 FY 2024 YoY
Current Assets
Cash & Cash Equivalents 566,021 757,355 -25.3%
Marketable Securities (Current) 201,607 — —
Accounts Receivable 158,587 134,115 +18.2%
Inventory 170,458 142,964 +19.2%
Prepaid Expenses & Other Current Assets 40,712 31,607 +28.8%
Total Current Assets 1,137,385 1,066,041 +6.7%
Non-Current Assets
Property, Plant & Equipment 186,614 197,738 -5.6%
Goodwill 1,114,408 1,030,995 +8.1%
Show Business Acquisition breakouts
908 Devices Inc. Bioprocessing Analytics Portfolio 50,177 — —
FlexBiosys, Inc. 14,321 — —
Metenova Holding AB 115,722 — —
Tantti Laboratory Inc. 46,943 46.9 +99991.7%
Deferred Tax Assets 694 749 -7.3%
Operating Lease Right-of-Use Assets 119,538 135,378 -11.7%
Other Non-Current Assets 4,913 868 +466.0%
Assets Noncurrent 1,812,314 1,763,625 +2.8%
Total Assets 2,949,699 2,829,666 +4.2%
Show Geography breakouts
APAC 119,594 113,844 +5.1%
Europe 489,927 410,284 +19.4%
North America 2,340,178 2,305,538 +1.5%
Intangible Assets 385,447 397,197 -3.0%
Show Finite Lived Intangible Assets By Major Class breakouts
Customer Relationships 157,491 166,953 -5.7%
Developed Technology Rights 219,899 223,108 -1.4%
Other Intangible Assets 443 778 -43.1%
Show Indefinite Lived Intangible Assets By Major Class breakouts
Trademarks 7,614 6,358 +19.8%
Other Assets
Intangible Assets Net Excluding Goodwill 386,147 397,897 -3.0%
Current Liabilities
Accounts Payable 30,010 32,134 -6.6%
Operating Lease Liability Current 21,559 15,104 +42.7%
Business Combination Contingent Consideration Liability Current 5,049 17,126 -70.5%
Accrued Liabilities 79,208 62,423 +26.9%
Total Current Liabilities 135,826 126,787 +7.1%
Deferred Revenue 14,609 13,243 +10.3%
Non-Current Liabilities
Long-Term Debt 542,213 525,567 +3.2%
Show Debt Instrument breakouts
1.00% Convertible Senior Notes due 2028 542,213 525,567 +3.2%
Deferred Tax And Other Liabilities Noncurrent 22,496 22,775 -1.2%
Operating Lease Liabilities 126,176 145,576 -13.3%
Business Combination Contingent Consideration Liability Noncurrent 1,304 19,662 -93.4%
Other Non-Current Liabilities 15,555 16,581 -6.2%
Liabilities Noncurrent 707,744 730,161 -3.1%
Total Liabilities 843,570 856,948 -1.6%
Stockholders' Equity
Common Stock 563 561 +0.4%
Additional Paid In Capital Common Stock 1,651,849 1,617,336 +2.1%
Accumulated Other Comprehensive Income -2,531 -52,533 +95.2%
Retained Earnings 456,248 407,354 +12.0%
Total Stockholders' Equity 2,106,129 1,972,718 +6.8%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -2,531 -52,533 +95.2%
Additional Paid In Capital 1,651,849 1,617,336 +2.1%
Common Stock 563 561 +0.4%
Retained Earnings 456,248 407,354 +12.0%
Total Liabilities & Equity 2,949,699 2,829,666 +4.2%

Cash Flow Statement

Cash Flow Statement
Metric FY 2025 FY 2024 YoY
Operating Activities
Net Income 48,894 -25,514 +291.6%
Show Equity Components breakouts
Retained Earnings 48,894 -25,514 +291.6%
Show Consolidation Items breakouts
Operating Segments 48,894 -25,514 +291.6%
Depreciation And Amortization 78,745 69,673 +13.0%
Amortization Of Financing Costs And Discounts 16,646 15,588 +6.8%
Inventory Step- Up Amortization 1,560 — —
Stock-Based Compensation 32,605 48,070 -32.2%
Show Income Statement Location breakouts
Cost Of Sales 2,682 1,948 +37.7%
Research And Development Expense 5,015 3,227 +55.4%
Selling General And Administrative Expenses 24,908 42,895 -41.9%
Deferred Income Taxes -3,373 -16,790 +79.9%
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 -13,607 3,191 -526.4%
Show Contingent Consideration By Type breakouts
Contingent Consideration -13,607 — —
Foreign Currency Transaction Gain Loss Before Tax -13,014 — —
Operating Lease Right Of Use Asset Amortization Expense 18,211 16,889 +7.8%
Other Non-Cash Items 1,630 3,366 -51.6%
Change in Accounts Receivable -17,165 -14,031 -22.3%
Change in Inventory -14,947 56,895 -126.3%
Change in Prepaid & Other Assets -7,756 1,553 -599.4%
Increase Decrease In Other Noncurrent Assets -1,560 471 -431.2%
Change in Accounts Payable -4,150 12,898 -132.2%
Increase Decrease In Accrued Liabilities 11,813 6,106 +93.5%
Increase Decrease In Operating Lease Liability -15,556 -8,292 -87.6%
Change in Other Liabilities -1,559 5,321 -129.3%
Net Cash from Operations 117,417 175,394 -33.1%
Investing Activities
Payments To Acquire Businesses Net Of Cash Acquired -70,328 -54,765 -28.4%
Payments To Acquire Marketable Securities -200,257 — —
Payments To Acquire Software -2,211 -4,222 +47.6%
Capital Expenditures -23,519 -25,677 +8.4%
Proceeds From Sale Of Property Plant And Equipment 238 — —
Other Investing Activities -2,397 1,287 -286.2%
Net Cash from Investing -298,474 -86,383 -245.5%
Financing Activities
Proceeds From Stock Options Exercised 3,176 4,294 -26.0%
Tax Withholding for Share Compensation -8,833 -9,882 +10.6%
Payment For Contingent Consideration Liability Financing Activities -9,548 -7,375 -29.5%
Show Contingent Consideration By Type breakouts
Contingent Consideration -9,548 — —
Net Cash from Financing -15,205 -82,902 +81.7%
Amortization of Financing Costs -1,660 -1,843 +9.9%
Show Debt Instrument breakouts
1.00% Convertible Senior Notes due 2028 -1,660 -1,636 -1.5%
Supplemental
Income Taxes Paid 20,925 19.3 +108319.7%
Right Of Use Asset Obtained In Exchange For Operating Lease Liability 5,352 37,894 -85.9%
Fair Value Of Shares Of Common Stock Issued For Contingent Consideration Earnouts 7,568 5,742 +31.8%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 4,928 -77 +6500.0%
Net Change in Cash -191,334 6,032 -3272.0%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 566,021 757,355 -25.3%

Values in thousands USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key